These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12469867)

  • 1. Inhibitory deficit in schizophrenia is not necessarily a GABAergic deficit.
    Lara DR
    Cell Mol Neurobiol; 2002 Jun; 22(3):239-47. PubMed ID: 12469867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat.
    Florán B; Barajas C; Florán L; Erlij D; Aceves J
    Neuroscience; 2002; 115(3):743-51. PubMed ID: 12435413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adenosine antagonist theophylline impairs p50 auditory sensory gating in normal subjects.
    Ghisolfi ES; Prokopiuk AS; Becker J; Ehlers JA; Belmonte-de-Abreu P; Souza DO; Lara DR
    Neuropsychopharmacology; 2002 Oct; 27(4):629-37. PubMed ID: 12377399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of intermittent oscillatory activity of pyramidal cell neurons by GABA inhibitory interneurons is impaired in schizophrenia: rationale for pharmacotherapeutic GABAergic interventions.
    Deutsch SI; Rosse RB; Schwartz BL; Mastropaolo J; Burket JA; Weizman A
    Isr J Psychiatry Relat Sci; 2010; 47(1):17-26. PubMed ID: 20686196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications.
    Lara DR; Dall'Igna OP; Ghisolfi ES; Brunstein MG
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):617-29. PubMed ID: 16580767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABA release modified by adenosine receptors in mouse hippocampal slices under normal and ischemic conditions.
    Saransaari P; Oja SS
    Neurochem Res; 2005 Apr; 30(4):467-73. PubMed ID: 16076017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine A1 receptors inhibit GABAergic transmission in rat tuberomammillary nucleus neurons.
    Yum DS; Cho JH; Choi IS; Nakamura M; Lee JJ; Lee MG; Choi BJ; Choi JK; Jang IS
    J Neurochem; 2008 Jul; 106(1):361-71. PubMed ID: 18397365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors.
    Díaz-Cabiale Z; Vivó M; Del Arco A; O'Connor WT; Harte MK; Müller CE; Martínez E; Popoli P; Fuxe K; Ferré S
    Neurosci Lett; 2002 May; 324(2):154-8. PubMed ID: 11988350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in excitatory and inhibitory brainstem interneuronal circuits after severe spinal cord injury.
    Kumru H; Vidal J; Kofler M; Portell E; Valls-Solé J
    J Neurotrauma; 2010 Apr; 27(4):721-8. PubMed ID: 20067395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
    Moxon KA; Gerhardt GA; Adler LE
    Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell.
    de Bruin NM; Ellenbroek BA; van Luijtelaar EL; Cools AR; Stevens KE
    Neuroscience; 2001; 105(1):169-80. PubMed ID: 11483310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder.
    Benes FM; Berretta S
    Neuropsychopharmacology; 2001 Jul; 25(1):1-27. PubMed ID: 11377916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.
    Boison D; Singer P; Shen HY; Feldon J; Yee BK
    Neuropharmacology; 2012 Mar; 62(3):1527-43. PubMed ID: 21315743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemistry and the schizophrenia. Old concepts and new hypothesis.
    Berger PA
    J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory control of sensory gating in a computer model of the CA3 region of the hippocampus.
    Moxon KA; Gerhardt GA; Gulinello M; Adler LE
    Biol Cybern; 2003 Apr; 88(4):247-64. PubMed ID: 12690484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A1 receptor-mediated presynaptic inhibition of GABAergic transmission in immature rat hippocampal CA1 neurons.
    Jeong HJ; Jang IS; Nabekura J; Akaike N
    J Neurophysiol; 2003 Mar; 89(3):1214-22. PubMed ID: 12626609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GABAergic system in schizophrenia.
    Blum BP; Mann JJ
    Int J Neuropsychopharmacol; 2002 Jun; 5(2):159-79. PubMed ID: 12135541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-lasting potentiation of GABAergic synapses in dopamine neurons after a single in vivo ethanol exposure.
    Melis M; Camarini R; Ungless MA; Bonci A
    J Neurosci; 2002 Mar; 22(6):2074-82. PubMed ID: 11896147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional neuroanatomy of the ventral striopallidal GABA pathway. New sites of intervention in the treatment of schizophrenia.
    O'Connor WT
    J Neurosci Methods; 2001 Aug; 109(1):31-9. PubMed ID: 11489297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of GABA(B) receptors reverses spontaneous gating deficits in juvenile DBA/2J mice.
    Bortolato M; Frau R; Orrù M; Piras AP; Fà M; Tuveri A; Puligheddu M; Gessa GL; Castelli MP; Mereu G; Marrosu F
    Psychopharmacology (Berl); 2007 Oct; 194(3):361-9. PubMed ID: 17604981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.